Meropenem Steriscience

Meropenem Trihydrate, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It treats severe bacterial infections, including intra‑abdominal, urinary tract, and respiratory infections, in hospitalized adult and pediatric patients. The drug is administered by infusion under medical supervision and is indicated for infections caused by susceptible Gram‑negative and Gram‑positive organisms.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem Steriscience, a carbapenem antibiotic, is used for serious infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: provides bactericidal activity to resolve infection and reduce mortality. - Complicated urinary tract infections: eradicates pathogenic organisms and restores urinary tract health. - Hospital‑acquired pneumonia: treats resistant respiratory pathogens to improve clinical outcomes. - Ventilator‑associated pneumonia: eliminates causative bacteria and supports recovery in ventilated patients. - Meningitis: penetrates the cerebrospinal fluid to combat central nervous system infections. - Severe sepsis and septic shock: offers rapid bacterial clearance to stabilize hemodynamics.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: localized skin erythema. - Infusion site phlebitis: pain or redness at the IV site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or high doses. - Clostridioides difficile colitis: severe diarrhea due to intestinal flora disruption.

Careful assessment and monitoring are required when using meropenem.

- Renal function: adjust dose in patients with impaired renal clearance. - Hepatic function: monitor liver enzymes in patients with liver disease. - Age: use caution in neonates and the elderly due to altered pharmacokinetics. - Concomitant valproic acid: monitor for increased risk of seizures. - Pregnancy: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meropenem may interact with other medicines; some combinations require avoidance, others close monitoring.

Major Interactions (Avoid): - Valproic acid: may reduce seizure control when combined. - Probenecid: can decrease renal excretion of meropenem, increasing toxicity risk.

Moderate Interactions (Monitor Closely): - Loop diuretics: potential additive nephrotoxicity. - Aminoglycosides: increased risk of kidney injury when used together. - Anticoagulants: may alter INR, requiring coagulation monitoring.